- Home
- SUPN vs ALRM Comparison
SUPN vs ALRM Comparison
Compare SUPN & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- ALRM
- Stock Information
- Founded
- SUPN 2005
- ALRM 2000
- Country
- SUPN United States
- ALRM United States
- Employees
- SUPN N/A
- ALRM N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- ALRM Computer Software: Prepackaged Software
- Sector
- SUPN Health Care
- ALRM Technology
- Exchange
- SUPN Nasdaq
- ALRM Nasdaq
- Market Cap
- SUPN 2.6B
- ALRM 2.8B
- IPO Year
- SUPN 2012
- ALRM 2015
- Fundamental
- Price
- SUPN $46.02
- ALRM $49.86
- Analyst Decision
- SUPN Strong Buy
- ALRM Hold
- Analyst Count
- SUPN 4
- ALRM 4
- Target Price
- SUPN $63.25
- ALRM $61.00
- AVG Volume (30 Days)
- SUPN 1.0M
- ALRM 342.4K
- Earning Date
- SUPN 11-04-2025
- ALRM 11-06-2025
- Dividend Yield
- SUPN N/A
- ALRM N/A
- EPS Growth
- SUPN N/A
- ALRM 1.77
- EPS
- SUPN N/A
- ALRM 2.36
- Revenue
- SUPN $681,539,000.00
- ALRM $991,770,000.00
- Revenue This Year
- SUPN $8.29
- ALRM $7.89
- Revenue Next Year
- SUPN $22.72
- ALRM $4.24
- P/E Ratio
- SUPN N/A
- ALRM $21.17
- Revenue Growth
- SUPN 4.54
- ALRM 7.36
- 52 Week Low
- SUPN $29.16
- ALRM $46.65
- 52 Week High
- SUPN $57.65
- ALRM $70.06
- Technical
- Relative Strength Index (RSI)
- SUPN 37.29
- ALRM 45.76
- Support Level
- SUPN $43.11
- ALRM $46.65
- Resistance Level
- SUPN $57.34
- ALRM $49.57
- Average True Range (ATR)
- SUPN 2.50
- ALRM 1.29
- MACD
- SUPN -0.98
- ALRM -0.09
- Stochastic Oscillator
- SUPN 19.60
- ALRM 50.87
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.